Biolase closes $14M stock offering

By staff writers

February 11, 2021 -- Biolase has closed its previously announced stock offering, generating proceeds of about $14.4 million.

The company offered 14 million shares of its common stock at a public price of $1.03 per share. The roughly $14 million in proceeds is before deducting underwriting discounts and commissions, according to the company. It is also before estimated offering expenses.

Biolase President and CEO Todd Norbe called the offering a success. The offering grew the company's cash to more than $40 million and provided resources for Biolase to move forward with its growth strategy, Norbe noted.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking